Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling

Pediatric Research

Volumn 57, Issue 5 I, 2005, Pages 631-636

  Ambalavanan, Namasivayam ^a,d   Bulger, Arlene ^a   Murphy Ullrich, Joanne ^b   Oparil, Suzanne ^c   Chen, Yiu Fai ^c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BQ 610; ENDOTHELIN A RECEPTOR ANTAGONIST;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COR PULMONALE; DRUG MECHANISM; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE HYPERTROPHY; LUNG BLOOD VESSEL; MORPHOMETRICS; MOUSE; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; OXYGEN BREATHING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; RECEPTOR BLOCKING; VASOCONSTRICTION;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; COTTONSEED OIL; DISEASE MODELS, ANIMAL; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; LUNG; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; OXYGEN; PULMONARY ARTERY; PULMONARY CIRCULATION; RECEPTOR, ENDOTHELIN A; TIME FACTORS;

EID: 17744367816     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000159512.55862.69     Document Type: Article

References (41)

1. Murphy JD, Vawter GF, Reid LM 1984 Pulmonary vascular disease in fatal meconium aspiration. J Pediatr 104:758-762
2. Drummond WH, Bissonnette JM 1978 Persistent pulmonary hypertension in the neonate: development of an animal model. Am J Obstet Gynecol 131:761-763
3. Stenmark KR, Fasules J, Hyde DM, Voelkel NF, Henson J, Tucker A, Wilson H, Reeves JT 1987 Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. J Appl Physiol 62:821-830
4. Fike CD, Kaplowitz MR 1994 Effect of chronic hypoxia on pulmonary vascular pressures in isolated lungs of newborn pigs. J Appl Physiol 77:2853-2862
5. Walsh-Sukys MC 1993 Persistent pulmonary hypertension of the newborn. The black box revisited. Clin Perinatol 20:127-143
6. Goodman G, Perkin RM, Anas NG, Sperling DR, Hicks DA, Rowen M 1988 Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 112:67-72
7. Hoffmeister HM, Apitz J, Hoffmeister HE, Fischbach H 1981 The correlation between blood pressure and morphometric findings in children with congenital heart disease and pulmonary hypertension. Basic Res Cardiol 76:647-656
8. Steinhorn RH, Fineman JR 1999 The pathophysiology of pulmonary hypertension in congenital heart disease. Artif Organs 23:970-974
9. Ziegler JW, Ivy DD, Kinsella JP, Abman SH 1995 The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation. Clin Perinatol 22:387-403
10. Ortega Mateo A, de Artinano AA 1997 Highlights on endothelins: a review. Pharmacol Res 36:339-351
11. Wong J, Vanderford PA, Fineman JR, Chang R, Soifer SJ 1993 Endothelin-1 produces pulmonary vasodilation in the intact newborn lamb. Am J Physiol 265:H1318-H1325
12. Bradley LM, Czaga JF, Goldstein RE 1990 Circulatory effects of endothelin in newborn piglets. Am J Physiol 259:H1613-H1617
13. Barnard JW, Barman SA, Adkins WK, Longenecker GL, Taylor AE 1991 Sustained effects of endothelin-1 on rabbit, dog, and rat pulmonary circulations. Am J Physiol 261:H479-H486
14. Sekine T, Kusano H, Nishimaru K, Tanaka Y, Tanaka H, Shigenobu K 1999 Developmental conversion of inotropism by endothelin I and angiotensin II from positive to negative in mice. Eur J Pharmacol 374:411-415
15. Giannessi D, Del Ry S, Andreassi MG, Nardini V, Pelosi G, Colombo MG, Biagini A 1999 High density of endothelin binding sites in the hearts of infants and children. Life Sci 64:697-705
16. Kumar P, Kazzi NJ, Shankaran S 1996 Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Am J Perinatol 13:335-341
17. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH 1993 Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 123:109-114
18. Ambalavanan N, Philips JB III, Bulger A, Oparil S, Chen YF 2002 Endothelin-A receptor blockade in porcine pulmonary hypertension. Pediatr Res 52:913-921
19. DiCarlo VS, Chen SJ, Meng QC, Durand J, Yano M, Chen YF, Oparil S 1995 ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am J Physiol 269:L690-L697
20. Chen SJ, Chen YF, Opgenorth TJ, Wessale JL, Meng QC, Durand J, DiCarlo VS, Oparil S 1997 The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. J Cardiovasc Pharmacol 29:713-725
21. Rabinovitch M, Gamble WJ, Miettinen OS, Reid L 1981 Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol 240:H62-H72
22. Kelly DA, Hislop AA, Hall SM, Haworth SG 2002 Correlation of pulmonary arterial smooth muscle structure and reactivity during adaptation to extrauterine life. J Vasc Res 39:30-40
23. Ebihara I, Nakamura T, Tomino Y, Koide H 1997 Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Nephrol Dial Transplant 12:1001-1006
24. Chen SJ, Chen YF, Meng QC, Durand J, Dicarlo VS, Oparil S 1995 Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol 79:2122-2131
25. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid L 1979 Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 236:H818-H827
26. Burri P 1997 Structural aspects of prenatal and postnatal development and growth for the lung. In: McDonald JA (ed) Lung Growth and Development. Dekker, New York, pp 1-35
27. Amy RW, Bowes D, Burri PH, Haines J, Thurlbeck WM 1977 Postnatal growth of the mouse lung. J Anat 124:131-151
28. Vicencio AG, Eickelberg O, Stankewich MC, Kashgarian M, Haddad GG 2002 Regulation of TGF-beta ligand and receptor expression in neonatal rat lungs exposed to chronic hypoxia. J Appl Physiol 93:1123-1130
29. Sekhon HS, Thurlbeck WM 1996 Lung morphometric changes after exposure to hypobaria and/or hypoxia and undernutrition. Respir Physiol 106:99-107
30. Ivy DD, Parker TA, Zeigler JW, Galan HL, Kinsella JP, Tuder RM, Abman SH 1997 Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest 99:1179-1186
31. Perreault T, Berkenbosch JW, Barrington KJ, Decker ER, Wu C, Brock TA, Baribeau J 2001 TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets. Pediatr Res 50:374-383
32. Rabinovitch M 1996 Cell-extracellular matrix interactions in the ductus arteriosus and perinatal pulmonary circulation. Semin Perinatol 20:531-541
33. Wohrley JD, Frid MG, Moiseeva EP, Orton EC, Belknap JK, Stenmark KR 1995 Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest 96:273-281
34. Das M, Dempsey EC, Reeves JT, Stenmark KR 2002 Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol Lung Cell Mol Physiol 282:L976-L986
35. Li H, Chen SJ, Chen YF, Meng QC, Durand J, Oparil S, Elton TS 1994 Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol 77:1451-1459
36. Aversa CR, Oparil S, Caro J, Li H, Sun SD, Chen YF, Swerdel MR, Monticello TM, Durham SK, Minchenko A, Lira SA, Webb ML 1997 Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice. Am J Physiol 273:L848-L855
37. Ivy DD, Kinsella JP, Abman SH 1994 Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest 93:2141-2148
38. Prendergast B, Newby DE, Wilson LE, Webb DJ, Mankad PS 1999 Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery. Heart 82:505-508
39. Schulze-Neick I, Li J, Reader JA, Shekerdemian L, Redington AN, Penny DJ 2002 The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease. J Thorac Cardiovasc Surg 124:435-441
40. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G 2002 Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346:896-903
41. Givertz MM, Colucci WS, Lejemtel TH, Gottlieb SS, Hare JM, Slawsky MT, Leier CV, Loh E, Nicklas JM, Lewis BE 2000 Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation 101:2922-2927